 |
Omeicos Therapeutics
Last updated: January 20, 2024
Founders: Robert Fischer, Karen Uhlmann
Country: Germany | Funding: $37.3M (+)
Website: http://www.omeicos.com/
OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.
Website: http://www.omeicos.com/
OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.
